Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IRB System Revisions Discussed At June 11 House Hearing

This article was originally published in The Gray Sheet

Executive Summary

Institutional review boards should not have to duplicate functions performed by industry or government, such as reviewing adverse event reports, the Health Industry Manufacturers Assocation says in written testimony submitted to the House Government Reform/Human Resources Subcommittee at a June 11 hearing on IRBs.

You may also be interested in...



Institutional Review Board “Shopping” Gauged By FDA As It Ponders Reg

FDA wants to determine whether promulgating regulations requiring sponsors and investigators to inform institutional review boards of prior reviews would affect overall IRB review times

Institutional Review Board “Shopping” Gauged By FDA As It Ponders Reg

FDA wants to determine whether promulgating regulations requiring sponsors and investigators to inform institutional review boards of prior reviews would affect overall IRB review times

FDA Clinical Investigator Oversight Weak On Recruitment Tactics, OIG Report

Protocol violations by medical device clinical investigators were cited in 78% (83/107) of official actions by FDA's Center for Devices and Radiological Health between fiscal years 1994-99, the HHS Office of Inspector General states in a report on FDA oversight of clinical investigators released June 12.

Related Content

UsernamePublicRestriction

Register

MT010194

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel